Biomedicine & Pharmacotherapy is a multidisciplinary journal which publishes full-length, original research reports, reviews, and preliminary communications or letters to the editor which fall within the general scope of clinical and basic medicine and pharmacology.
The general fields of interest will include Cancer, Nutriceutics, Neurodegenerative, Cardiac and Infectious Diseases.
Special emphasis will be placed on studies of specific topics such as molecular mechanisms, gene regulation in normal and pathologic cells as well as susceptibility in response to oncogenic agents. Effects of drugs on preclinical and clinical pharmacology and the role of bacteria, viruses and parasites in animals and humans.
Brief reports of meetings, symposia and conferences will also be considered for publication as well as brief listings of scientific meetings or academic courses of interest to the readers
《Biomedicine & Pharmacotherapy》是一本由ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER出版商出版的专业医学期刊,该刊创刊于1982年,刊期Monthly,该刊已被国际权威数据库SCIE、SCI收录。在中科院最新升级版分区表中,该刊分区信息为大类学科:医学 2区,小类学科:药学 1区;医学:研究与实验 2区;在JCR(Journal Citation Reports)分区等级为Q1。该刊发文范围涵盖医学:研究与实验等领域,旨在及时、准确、全面地报道国内外医学:研究与实验工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等,促进学术交流,鼓励学术创新。2021年影响因子为7.419,平均审稿速度平均2月。
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
医学 | 2区 | PHARMACOLOGY & PHARMACY 药学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 | 1区 2区 | 是 | 否 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q1 | PHARMACOLOGY & PHARMACY | Q1 | 7.419 |
MEDICINE, RESEARCH & EXPERIMENTAL | Q1 |
影响因子 | h-index | Gold OA文章占比 | 研究类文章占比 | OA开放访问 | 平均审稿速度 |
7.419 | 78 | 99.60% | 75.99% | 未开放 | 平均2月 |